Poly Medicure Gestion
Gestion contrôle des critères 2/4
Le PDG Poly Medicure est Himanshu Baid, nommé en Sep1995, a un mandat de 29.17 ans. La rémunération annuelle totale est ₹ 171.78M, composée du salaire de 33.6% et des bonus 66.4%, y compris les actions et options de la société. détient directement 11.59% des actions de la société, d'une valeur de ₹ 30.58B. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 6.4 ans et 8.4 ans.
Informations clés
Himanshu Baid
Directeur général
₹171.8m
Rémunération totale
| Pourcentage du salaire du PDG | 33.6% |
| Durée du mandat du directeur général | 29.2yrs |
| Propriété du PDG | 11.6% |
| Durée moyenne d'occupation des postes de direction | 6.4yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 8.4yrs |
Mises à jour récentes de la gestion
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Recent updates
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge
Nov 02Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹172m | ₹58m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹130m | ₹55m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹1b |
| Jun 30 2022 | n/a | n/a | ₹1b |
| Mar 31 2022 | ₹107m | ₹49m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹92m | ₹44m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹1b |
| Sep 30 2020 | n/a | n/a | ₹1b |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹62m | ₹35m | ₹959m |
| Dec 31 2019 | n/a | n/a | ₹947m |
| Sep 30 2019 | n/a | n/a | ₹858m |
| Jun 30 2019 | n/a | n/a | ₹719m |
| Mar 31 2019 | ₹44m | ₹14m | ₹654m |
| Mar 31 2018 | ₹41m | ₹14m | ₹706m |
Rémunération vs marché: La rémunération totale de Himanshu ($USD 2.03M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 618.18K ).
Rémunération et revenus: La rémunération de Himanshu a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
Himanshu Baid (56 yo)
29.2yrs
Titularisation
₹171,781,000
Compensation
Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Director | 29.2yrs | ₹171.78m | 11.59% ₹ 30.6b | |
| Founder & Non Executive Director | no data | ₹1.43m | 2.25% ₹ 5.9b | |
| Chief Financial Officer | 3.3yrs | ₹11.21m | pas de données | |
| Company Secretary & Compliance Officer | 9.5yrs | ₹1.88m | pas de données | |
| Joint MD & Executive Director | no data | ₹166.82m | 12.38% ₹ 32.7b | |
| President of Corporate Sales & Marketing | 2.6yrs | ₹18.39m | 1.66% ₹ 4.4b | |
| Assistant Vice President of Finance & Accounts | no data | pas de données | pas de données | |
| Senior Vice President of Domestic Sales & Marketing | no data | ₹5.79m | pas de données | |
| President of R&D | no data | ₹5.61m | pas de données | |
| President of Sales & Marketing - India | no data | ₹8.61m | pas de données |
6.4yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Gestion expérimentée: L'équipe dirigeante de POLYMED est chevronnée et expérimentée (6.4 années d'ancienneté moyenne).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Director | 29.7yrs | ₹171.78m | 11.59% ₹ 30.6b | |
| Founder & Non Executive Director | 29.7yrs | ₹1.43m | 2.25% ₹ 5.9b | |
| Joint MD & Executive Director | 29.7yrs | ₹166.82m | 12.38% ₹ 32.7b | |
| Non-Executive Independent Director | less than a year | pas de données | pas de données | |
| Non-Executive Independent Director | 4.4yrs | ₹1.60m | pas de données | |
| Non-Executive Independent Chairman | 19.5yrs | ₹1.63m | pas de données | |
| Non-Executive Director | 10.3yrs | ₹1.43m | 3.02% ₹ 8.0b | |
| Non-Executive Independent Director | 4.3yrs | ₹1.45m | pas de données | |
| Non-Executive Non Independent Director | 6.5yrs | ₹29.90m | pas de données | |
| Independent Director | 2.6yrs | ₹1.45m | pas de données |
8.4yrs
Durée moyenne de l'emploi
64.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de POLYMED sont considérés comme expérimentés (ancienneté moyenne 8.4 ans).